Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Shares withheld for taxes Chief Executive Officer gave up 457 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP and CFO gave up 176 shares (to pay taxes)
  8. 4 Shares withheld for taxes See Remarks gave up 164 shares (to pay taxes)
  9. 4/A Shares withheld for taxes See Remarks gave up 370 shares (to pay taxes)
  10. 4 Shares withheld for taxes See Remarks gave up 176 shares (to pay taxes)
  11. 4 Grant or award See Remarks acquired 1,000 shares (grant or award)
  12. 4 Open-market sale Director sold 87,500 shares at an average $0.60 ($52,773)
  13. 4 Open-market sale Director sold 22,698 shares at $0.55 ($12,484)
  14. 4 Grant or award Director acquired 7,500 shares (grant or award)
  15. 4 Grant or award Director acquired 7,500 shares (grant or award)
  16. 4 Grant or award Director acquired 7,500 shares (grant or award)
  17. 4 Grant or award Director acquired 7,500 shares (grant or award)
  18. 4 Grant or award Director acquired 7,500 shares (grant or award)
  19. 4 Grant or award Director acquired 7,500 shares (grant or award)
  20. 4/A Open-market sale Director sold 77,302 shares at an average $0.55 ($42,540)

Page 9 of 33 · 648 filings